111 related articles for article (PubMed ID: 21048312)
21. Intracranial invasive aspergillosis originating in the sphenoid sinus: a successful treatment with high-dose itraconazole in three cases.
Yamanoi T; Shibano K; Soeda T; Hoshi A; Matsuura Y; Sugiura Y; Endo K; Yamamoto T
Tohoku J Exp Med; 2004 Jun; 203(2):133-9. PubMed ID: 15212149
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan.
Ohta K; Nishiki Kosaka S; Nakao Y; Kumura T; Hagihara K; Sakamoto E; Okamoto S; Hirose A; Aoyama Y; Yamamura R; Hayashi Y; Umemoto Y; Terada Y; Takeoka Y; Nakane T; Koh H; Hino M
Int J Hematol; 2009 Jun; 89(5):649-55. PubMed ID: 19449195
[TBL] [Abstract][Full Text] [Related]
23. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Myoken Y; Sugata T; Kyo T; Fujihara M; Mikami Y
J Periodontol; 2002 Jan; 73(1):33-8. PubMed ID: 11846198
[TBL] [Abstract][Full Text] [Related]
24. Measurement of posaconazole, itraconazole, and hydroxyitraconazole in plasma/serum by high-performance liquid chromatography with fluorescence detection.
Buckner SL; Ceesay MM; Pagliuca A; Morgan PE; Flanagan RJ
Ther Drug Monit; 2011 Dec; 33(6):735-41. PubMed ID: 22105591
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of antifungal prophylaxis with oral itraconazole solution among patients receiving corticosteroids: who should be given prophylaxis?
Iriyama N; Matsukawa Y; Miura K; Inomata H; Hirabayashi Y; Hatta Y; Horikoshi A; Takeuchi J
J Infect Chemother; 2011 Dec; 17(6):744-9. PubMed ID: 21523410
[TBL] [Abstract][Full Text] [Related]
26. Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
Tzadok R; Shapira MY; Moses AE; Or R; Block C; Strahilevitz J
Mycoses; 2015 Dec; 58(12):694-8. PubMed ID: 26429354
[TBL] [Abstract][Full Text] [Related]
27. Antifungal use and therapeutic monitoring of plasma concentrations of itraconazole in heart and lung transplantation patients.
Brett J; Chong O; Graham GG; Ray JE; Marriott D; Williams KM; Day RO
Ther Drug Monit; 2013 Feb; 35(1):133-6. PubMed ID: 23188182
[TBL] [Abstract][Full Text] [Related]
28. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
[TBL] [Abstract][Full Text] [Related]
29. Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients.
Hennig S; Wainwright CE; Bell SC; Miller H; Friberg LE; Charles BG
Clin Pharmacokinet; 2006; 45(11):1099-114. PubMed ID: 17048974
[TBL] [Abstract][Full Text] [Related]
30. [Itraconazole-induced hypokalemia in a patient with pulmonary aspergilloma].
Sasaki E; Maesaki S; Kawamura S; Kakeya H; Ohno H; Hirakata Y; Tomono K; Ohzono Y; Tashiro T; Kohno S
Nihon Kokyuki Gakkai Zasshi; 1999 Jan; 37(1):36-40. PubMed ID: 10087874
[TBL] [Abstract][Full Text] [Related]
31. Hydroxy-itraconazole pharmacokinetics is similar to that of itraconazole in immunocompromised patients receiving oral solution of itraconazole.
Mino Y; Naito T; Watanabe T; Yamada T; Yagi T; Yamada H; Kawakami J
Clin Chim Acta; 2013 Jan; 415():128-32. PubMed ID: 23089073
[TBL] [Abstract][Full Text] [Related]
32. [Itraconazole 800 mg for the prophylaxis of fungal infections in patients with acute leukemia and severe neutropenia].
Andrade M A; Puga L B; Guerra C C; Molina E J; Capurro C M
Rev Med Chil; 2011 Sep; 139(9):1128-34. PubMed ID: 22215390
[TBL] [Abstract][Full Text] [Related]
33. [Prophylactic use of oral itraconazole solution for febrile neutropenia associated with hematologic malignancies].
Nakagawa Y; Suzuki N
Jpn J Antibiot; 2008 Apr; 61(2):102-4. PubMed ID: 18709732
[No Abstract] [Full Text] [Related]
34. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.
Jeong SH; Kim DY; Jang JH; Mun YC; Choi CW; Kim SH; Kim JS; Park JS
Ann Hematol; 2016 Jan; 95(2):337-44. PubMed ID: 26596974
[TBL] [Abstract][Full Text] [Related]
36. Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units.
Vandewoude K; Vogelaers D; Decruyenaere J; Jaqmin P; De Beule K; Van Peer A; Woestenborghs R; Groen K; Colardyn F
Antimicrob Agents Chemother; 1997 Dec; 41(12):2714-8. PubMed ID: 9420044
[TBL] [Abstract][Full Text] [Related]
37. Modulation of the human interleukin-12p40 response by a triazole antifungal derivative, itraconazole.
Inoue H; Iwasaki H; Abe S; Yamaguchi H; Ueda T
Scand J Infect Dis; 2004; 36(8):607-9. PubMed ID: 15370674
[TBL] [Abstract][Full Text] [Related]
38. [Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
Minenko SV; Zhukov NV; Chimishkian KL; Sokolova EN; Ptushkin VV
Antibiot Khimioter; 2004; 49(8-9):52-6. PubMed ID: 15727147
[TBL] [Abstract][Full Text] [Related]
39. Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis.
Cartledge JD; Midgely J; Gazzard BG
J Clin Pathol; 1997 Jun; 50(6):477-80. PubMed ID: 9378812
[TBL] [Abstract][Full Text] [Related]
40. Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents.
Fujita Y; Araki T; Okada Y; Aomori T; Shimizu R; Tomizawa T; Hiromura K; Nojima Y; Nakamura T; Yamamoto K
J Clin Pharm Ther; 2013 Feb; 38(1):74-6. PubMed ID: 22971159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
